The U.S. Food and Drug Administration (FDA) has granted fast track designation to muzastotug when used in combination with Keytruda (pembrolizumab) to treat adult patients with microsatellite stable ...
The FDA's fast track designation acknowledges the combination's promising early efficacy and safety profile in treating MSS mCRC. Early data from a phase 1b/2 study showed deep, durable responses with ...
23 小时on MSN
Here’s what hit Delcath Systems (DCTH) in Q3
Riverwater Partners, an investment management company, released its “Micro Opportunities Strategy” Q3 2025 investor letter. A ...
The headline has been edited for length purposes.SEMINOLE — When Anita Froese’s middle child came down with fatigue, body ...
Dear Shareholders, As we close out the year and step with confidence and purpose into 2026, I want to extend my sincere appreciation for your ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈